Elite Pharmaceuticals, Inc. Current Assets
Elite Pharmaceuticals, Inc. (ELTP) had Current Assets of $114.49 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Assets › Assets, Current
us-gaap:AssetsCurrent · last filed 2026-08-13
- 2026-06-30: Assets, Current $114.49M.
- 2026-03-31: Assets, Current $112.11M.
- 2025-12-31: Assets, Current $96.79M.
- 2025-09-30: Assets, Current $85.79M.
| Period end | Assets, Current | Assets, Current as first filed |
|---|---|---|
| 2026-06-30 | $114.49M 10-Q · filed 2026-08-13 | |
| 2026-03-31 | $112.11M 10-Q · filed 2026-08-13 | |
| 2025-12-31 | $96.79M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $85.79M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $77.86M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | $57.74M 10-K · filed 2026-06-29 | |
| 2024-12-31 | $48.05M 10-Q · filed 2025-02-13 | |
| 2024-09-30 | $45.29M 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $43.16M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | $40.01M 10-K · filed 2025-06-30 | |
| 2023-12-31 | $37.16M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $34.73M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $27.44M 10-Q · filed 2023-08-14 | |
| 2023-03-31 | $21.51M 10-K · filed 2024-07-01 | |
| 2022-12-31 | $33.16M 10-Q · filed 2023-02-14 | |
| 2022-09-30 | $30.47M 10-Q · filed 2022-11-14 | |
| 2022-06-30 | $31.87M 10-Q · filed 2022-08-15 | |
| 2022-03-31 | $18.86M 10-K · filed 2023-06-29 | |
| 2021-12-31 | $17.48M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $15.88M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $15.32M 10-Q · filed 2021-08-16 | |
| 2021-03-31 | $12.19M 10-K · filed 2022-06-29 | |
| 2020-12-31 | $14.54M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $13.28M 10-Q · filed 2020-11-16 | |
| 2020-06-30 | $13.25M 10-Q · filed 2020-08-14 | |
| 2020-03-31 | $10.25M 10-K · filed 2021-06-14 | |
| 2019-12-31 | $9.04M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $8.12M 10-Q · filed 2019-11-12 | |
| 2019-06-30 | $8.53M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $8.86M 10-K · filed 2020-06-29 | |
| 2018-12-31 | $9.43M 10-Q · filed 2019-02-11 | |
| 2018-09-30 | $10.38M 10-Q · filed 2018-11-09 | |
| 2018-06-30 | $11.46M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $13.70M 10-K · filed 2019-06-21 | |
| 2017-12-31 | $14.76M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $14.61M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $16.44M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $18.41M 10-K · filed 2018-06-14 | |
| 2016-12-31 | $20.62M 10-Q · filed 2017-02-09 | |
| 2016-09-30 | $19.66M 10-Q · filed 2016-11-09 | |
| 2016-06-30 | $17.99M 10-Q · filed 2016-08-09 | |
| 2016-03-31 | $16.71M 10-K · filed 2017-06-14 | |
| 2015-12-31 | $12.42M 10-Q · filed 2016-02-09 | |
| 2015-09-30 | $14.10M 10-Q · filed 2015-12-30 | |
| 2015-06-30 | $15.78M 10-Q · filed 2015-12-30 | |
| 2015-03-31 | $12.33M 10-K · filed 2016-06-15 | $12.33M 10-K · filed 2015-06-15 |
| 2014-12-31 | $13.19M 10-Q · filed 2015-02-17 | |
| 2014-09-30 | $11.71M 10-Q · filed 2014-11-14 | |
| 2014-06-30 | $12.08M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $9.92M 10-K · filed 2015-06-15 | |
| 2013-12-31 | $3.92M 10-Q · filed 2014-02-14 | |
| 2013-09-30 | $3.28M 10-Q · filed 2013-11-14 | |
| 2013-06-30 | $1.79M 10-Q · filed 2013-08-14 | |
| 2013-03-31 | $2.54M 10-K · filed 2014-06-30 | |
| 2012-12-31 | $1.64M 10-Q · filed 2013-02-14 | |
| 2012-09-30 | $1.36M 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $1.42M 10-Q · filed 2012-08-14 | |
| 2012-03-31 | $1.50M 10-K · filed 2013-06-21 | |
| 2011-12-31 | $1.54M 10-Q · filed 2012-02-14 | |
| 2011-09-30 | $2.08M 10-Q · filed 2011-11-14 | |
| 2011-06-30 | $2.67M 10-Q/A · filed 2011-08-19 | |
| 2011-03-31 | $3.15M 10-K · filed 2012-06-29 |